| Literature DB >> 9617338 |
Abstract
Recombinant adeno-associated virus (AAV) has attracted considerable interest as a potential vector for human gene therapy, but its transduction efficiency is quite low. The present study demonstrated AAV vector-associated liposomes to be more effective for in vitro gene transfer to human glioma cells than are liposomes containing plasmid DNA. Using vector-associated liposomes increased the transduction efficiency more than 10-fold compared to liposomes containing plasmid DNA and more than 6-fold compared to AAV alone. From these results, AAV vector-associated liposomes appear to be a good candidate for in vivo gene delivery to human gliomas.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9617338 PMCID: PMC5921812 DOI: 10.1111/j.1349-7006.1998.tb00570.x
Source DB: PubMed Journal: Jpn J Cancer Res ISSN: 0910-5050